In the TOGETHER-PsA trial, Merola and colleagues assessed the efficacy and safety of combination therapy with ixekizumab (Taltz, Eli Lilly) plus tirzepatide (Zepbound, Eli Lilly), compared with ixekizumab alone in a cohort of 271 adults with active PsA and overweight or obesity, aligned with the on-label dosing of both interventions
it is possible that claimed benefits could have been changed during the dispensation at the pharmacy, in addition to the fact that the benefit could have been changed by the prescriber over time
If you miss a dose of Mounjaro, follow specific protocols to get back on track
The most rigorous research protocols document reconstitution volumes, final concentrations, and injection volumes in methods sectionsnot as supplementary details, but as primary reproducibility criteria
2017), increases absorption (Feng et al